Cintas Corporation

NASDAQ:CTAS

Specialty Business Services

Industrials
$222.00 +0.73%

+$1.23 today

Market cap
$88.15B
Beta
0.93
P/E (TTM)
35.4
EPS (TTM)
$4.82
Dividend yield
1.05%
52W Low $161.16High $226.75

Volume 1.70M

Average 2.28M

CTAS Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Cintas CorporationNASDAQ: CTAS

Research & Development · Q1 FY2027 · quarter ended Aug 2026

Research & development remains negative

Q1 FY2027 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2026, down 0.3 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterAug 2026
$0— QoQ
Last fiscal yearMay 2026
$0-100.0% YoY
LTMAug 2026
$0-100.0% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2026
0 USD
Year-over-year change
-100.0%

Research & Development vs competitors

How CTAS compares with its peers on the latest reported figures

  • CTAS's LTM Aug 2026 research & development of $0 is the highest of the 3 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for CTAS, versus a peer median of 0.0%.
CTAS Competitors Peer median
Research & Development for CTAS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CTASCintas CorporationLTM Aug 2026$0 -100.0%—0.0%
ARMKAramarkLTM Oct 2026$0 ——0.0%
UNFUniFirst CorporationLTM Aug 2026$0 ——0.0%
Peer median (excluding CTAS) $0——0.0%

Competitors are the stored peer set for CTAS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Revenue7.85B8.82B9.6B10.34B11.26B
Cost of Revenue4.22B4.64B4.91B5.17B5.57B
Gross Profit3.63B4.17B4.69B5.17B5.69B
Gross Margin46.2%47.3%48.8%50.0%50.5%
Research & Development23.5M24.5M26.6M30.8M0
Selling, General & Admin2.04B2.37B2.62B2.81B3.09B
Operating Expenses2.04B2.37B2.62B2.81B3.09B
Depreciation & Amortization399.7M409.16M442.38M494.18M512.85M
EBITDA1.99B2.22B2.52B2.86B3.12B
EBITDA Margin25.3%25.2%26.3%27.7%27.7%
Operating Income1.59B1.8B2.07B2.36B2.61B
Operating Margin20.2%20.4%21.6%22.8%23.1%
Interest Income242K1.72M5.74M5.58M5.11M
Interest Expense88.84M111.23M100.74M101.11M106.29M
Other Income / Expenses(88.6M)(109.52M)(95M)(95.52M)(101.18M)
Income Before Tax1.5B1.69B1.97B2.26B2.51B
Pre-Tax Margin19.1%19.2%20.6%21.9%22.2%
Income Tax Expense263.01M345.14M402.04M451.92M505.37M
Net Income1.24B1.35B1.57B1.81B2B
Net Margin15.7%15.3%16.4%17.5%17.8%
EPS (Basic)2.983.303.854.484.97
EPS (Diluted)2.913.253.794.404.91
Weighted Avg Shares412.69M406.58M406.61M403.53M401.27M
Weighted Avg Shares (Diluted)422.09M413.51M413.47M410.29M406.2M

Cintas Corporation

NASDAQ:CTAS

Intrinsic Alpha fair value

Locked

Current Price

$222.00

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.